| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1148/RADIOLOGY.188.1.8511292 |
| P698 | PubMed publication ID | 8511292 |
| P2093 | author name string | Barrett BJ | |
| Carlisle EJ | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 171-178 | |
| P577 | publication date | 1993-07-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media | |
| P478 | volume | 188 |
| Q44623074 | A New Animal Model for Testing Renal Tolerance of Contrast Agents |
| Q42164585 | A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam |
| Q44487840 | A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study |
| Q46878631 | Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug. |
| Q44054777 | Acetylcysteine and contrast agent-associated nephrotoxicity |
| Q83736582 | Acute kidney injury |
| Q34114127 | Acute kidney injury by radiographic contrast media: pathogenesis and prevention. |
| Q83839654 | Acute renal failure |
| Q73892882 | Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality |
| Q35021674 | Acute renal failure induced by contrast medium: steps towards prevention |
| Q72154569 | Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application |
| Q77519807 | Adverse effects of contrast media: incidence, prevention and management |
| Q34289859 | American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consens |
| Q45136775 | Angioplasty and stenting of arterial stenosis affecting renal transplant function |
| Q39511427 | Arteriography in chronic renal failure: a case for carbon dioxide |
| Q37166265 | Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention |
| Q35160480 | Atorvastatin and prevention of contrast induced nephropathy following coronary angiography |
| Q90412757 | Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy |
| Q34574872 | Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction |
| Q79924895 | Causes and prognosis of nontraumatic acute renal failure requiring dialysis in adult patients with and without diabetes |
| Q40636025 | Cellular internalization and morphological analysis after intravenous injection of a highly hydrophilic octahedral rhenium cluster complex - a new promising X-ray contrast agent. |
| Q36628918 | Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics |
| Q35009423 | Comparative tolerability of contrast media used for coronary interventions |
| Q43206247 | Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. |
| Q74320159 | Computed tomography scan versus ventilation-perfusion lung scan in the detection of pulmonary embolism |
| Q26801447 | Contrast Medium-Induced Acute Kidney Injury |
| Q24236200 | Contrast agents for preventing contrast-induced nephropathy |
| Q24241747 | Contrast agents for preventing contrast-induced nephropathy |
| Q46099614 | Contrast induced nephropathy |
| Q37922124 | Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines |
| Q79703607 | Contrast induced obstructive anuria in uretero-pelvic junction obstruction secondary to a crossing vessel in a solitary kidney |
| Q34152802 | Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention |
| Q41821811 | Contrast media: are there differences in nephrotoxicity among contrast media? |
| Q88868587 | Contrast medium induced acute kidney injury: a narrative review |
| Q79291352 | Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations |
| Q41889016 | Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention |
| Q36971717 | Contrast safety in the cancer patient: preventing contrast-induced nephropathy |
| Q34155673 | Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention |
| Q49833841 | Contrast-associated acute kidney injury is a myth: No. |
| Q91641473 | Contrast-associated acute kidney injury: does it really exist, and if so, what to do about it? |
| Q54280256 | Contrast-induced Nephropathy. |
| Q35766187 | Contrast-induced acute kidney injury and diabetic nephropathy. |
| Q33752736 | Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). |
| Q39370384 | Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning |
| Q35127308 | Contrast-induced acute kidney injury: short- and long-term implications |
| Q30439077 | Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology |
| Q36761998 | Contrast-induced nephropathy following angiography and cardiac interventions |
| Q34566485 | Contrast-induced nephropathy: definition, epidemiology, and patients at risk |
| Q37483551 | Contrast-induced nephropathy: pathogenesis and prevention |
| Q37078519 | Contrast-induced nephropathy: update with special emphasis on patients with diabetes |
| Q37843545 | Contrast-induced nephropathy: what we know, what we think we know, and what we don't know |
| Q35622659 | Critical issues in nephrology |
| Q52973910 | Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catherization in patients with cyanotic congenital heart disease. |
| Q36969377 | Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level |
| Q35048384 | Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention. |
| Q34257105 | Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial |
| Q40902529 | Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity |
| Q89743199 | Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial |
| Q74598235 | Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency |
| Q71788769 | Efficacy assessment of imaging technologies and contrast media |
| Q38053772 | Endothelial safety of radiological contrast media: why being concerned. |
| Q37376716 | Evaluation of adverse reactions to contrast media in the hospital. |
| Q54601182 | Evaluation of brain and kidney energy metabolism in an animal model of contrast-induced nephropathy. |
| Q58739819 | Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study |
| Q35720598 | Evaluation of the patient with hematuria |
| Q34080177 | Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography. |
| Q80079525 | Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections |
| Q45043102 | Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group. |
| Q45334831 | Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group |
| Q26864323 | Hemodynamic and tubular changes induced by contrast media |
| Q53471404 | Imaging patients with chronic kidney disease: CIN or NSF? |
| Q37108314 | Impact of low hemoglobin on the development of contrast-induced nephropathy: A retrospective cohort study |
| Q33861539 | Impact of the interval between coronary angiography and off-pump coronary bypass surgery on postoperative renal function. |
| Q40654921 | Incidence of persistent renal dysfunction after contrast enhanced coronary CT angiography in patients with suspected coronary artery disease |
| Q30787528 | Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: a potential cause of Nephrotoxicity |
| Q40918968 | Interleukin 18 and neutrophil-gelatinase associated lipocalin in assessment of the risk of contrast-induced nephropathy in children |
| Q24248104 | Interventions for preventing contrast-induced nephropathy |
| Q46891078 | Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury |
| Q64953393 | Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI. |
| Q38209679 | Is contrast medium osmolality a causal factor for contrast-induced nephropathy? |
| Q44725588 | Is elevated creatinine level a contraindication to endovascular aneurysm repair? |
| Q83897948 | Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis |
| Q42592941 | Management of transplant renal artery stenosis |
| Q35584286 | N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial |
| Q36136330 | Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies |
| Q39389778 | Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review |
| Q30319678 | Nephrotoxicity as a cause of acute kidney injury in children. |
| Q42278871 | Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study |
| Q44404852 | Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slices |
| Q27023336 | Nonpharmacological strategies to prevent contrast-induced acute kidney injury |
| Q35813673 | Percutaneous coronary intervention in diabetics |
| Q35177924 | Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration |
| Q24187680 | Pharmacological interventions for preventing contrast-induced nephropathy |
| Q24247319 | Pharmacological interventions for preventing contrast-induced nephropathy |
| Q50090707 | Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. |
| Q35722883 | Preventing contrast nephropathy: what is the best strategy? A review of the literature |
| Q46164825 | Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography |
| Q35999430 | Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography |
| Q59100924 | Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors |
| Q77769448 | Prophylaxis against contrast-induced nephropathy |
| Q27012899 | Prophylaxis of contrast-induced nephrotoxicity |
| Q77481567 | Quality improvement guidelines for diagnostic arteriography |
| Q35124685 | Radiocontrast-induced nephropathy and percutaneous coronary intervention: a review of preventive measures |
| Q27021421 | Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies |
| Q93609063 | References |
| Q46917324 | Renal function and cardiac angiography |
| Q24187689 | Renal replacement therapy for preventing contrast-induced nephropathy |
| Q24245389 | Renal replacement therapy for preventing contrast-induced nephropathy |
| Q35367197 | Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT. |
| Q74667348 | Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review |
| Q27025085 | Risks and complications of coronary angiography: a comprehensive review |
| Q46894247 | Role of N-acetylcysteine on renal function in patients after orthotopic heart transplantation undergoing coronary angiography |
| Q87393341 | Section 4: Contrast-induced AKI |
| Q36448316 | Selection of contrast media |
| Q26853304 | Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention |
| Q33435406 | Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials |
| Q28082710 | Strategies for managing aortoiliac occlusions: access, treatment and outcomes |
| Q50095994 | Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis |
| Q53479433 | The dogma that gadolinium contrast media are less nephrotoxic than iodine agents for X-ray angiography is a misconception. |
| Q37692670 | The effect of L-carnitine on oxidative stress responses of experimental contrast-induced nephropathy in rats |
| Q46625271 | The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy |
| Q53151005 | The hematological and clinical effects of X-ray contrast medium contaminating autologous blood for transfusion purposes. |
| Q86886089 | The incidence of contrast medium-induced nephropathy following endovascular aortic aneurysm repair: assessment of risk factors |
| Q43999609 | The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents |
| Q71510841 | The responsibility of contrast media companies in the costs and benefits of radiology: giving the radiologist a real choice |
| Q35026504 | Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy. |
| Q36875662 | Ureteric colic: new trends in diagnosis and treatment |
| Q44996513 | Urine protein as a rapid screen for renal function in the ED: can it replace serum creatinine in selected patients? |
| Q35107640 | Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trial |
| Q37527194 | Vascular complications in renal transplantation: a single-center experience in 1367 renal transplantations and review of the literature |
| Q83879604 | [Myocardial revascularization in patients with chronic renal failure] |
| Q53305718 | [Value of whole body CTA in the management of brain-dead patients]. |
| Q73697010 | [What is reliable in prevention of contrast medium-induced nephropathy?] |
Search more.